Aderamastat | Interleukin Related interleukin-related.com

Product Name :
Aderamastat

Search keywords :
Aderamastat

drugId :
null

Target Vo:
Matrix metalloproteinase 12

Target Vo Short Name :
MMP12

Moa_Name:
Matrix metalloproteinase 12 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Foresee Pharmaceuticals Co Ltd

Active Company_Name :
Foresee Pharmaceuticals Co Ltd

Active Indication_Name:
Allergic asthma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Moxetumomab In Vivo
Phospho-Nrf2(S40)Rabbit mAb web
LDLR Antibody: LDLR Antibody is an unconjugated, approximately 92 kDa, rabbit-derived, anti-LDLR polyclonal antibody. LDLR Antibody can be used for: WB, ELISA, Flow-Cyt, ICC expriments in human, mouse, and predicted: rat, dog, pig, cow, horse, rabbit, guinea pig background without labeling.

Author: Interleukin Related

Related Posts